Related references
Note: Only part of the references are listed.Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19
M. L. Solodky et al.
ANNALS OF ONCOLOGY (2020)
Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Jiuxin Qu et al.
CLINICAL INFECTIOUS DISEASES (2020)
Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
Li Guo et al.
CLINICAL INFECTIOUS DISEASES (2020)
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Juanjuan Zhao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho
Andrew Bryan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
Profile of specific antibodies to SARS-CoV-2: The first report
Ai Tang Xiao et al.
JOURNAL OF INFECTION (2020)
Detection of antibodies against SARS-CoV-2 in patients with COVID-19
Zhe Du et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
Qingqing Lin et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
Antibody responses to SARS-CoV-2 in patients with COVID-19
Quan-Xin Long et al.
NATURE MEDICINE (2020)
Outcomes of COVID-19 in patients with CLL: a multicenter international experience
Anthony R. Mato et al.
BLOOD (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Perturbation of the normal immune system in patients with CLL
Francesco Forconi et al.
BLOOD (2015)
Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance
HY Mo et al.
RESPIROLOGY (2006)
Vaccination against infections in chronic lymphocytic leukemia
M Sinisalo et al.
LEUKEMIA & LYMPHOMA (2003)
Share Paper
